Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard ...
Phase Ib Study of BI 836880 (VEGF/Ang2 nanobody) in Combination With Ezabenlimab (anti–PD-1 antibody) in Patients With Advanced or Metastatic Solid Tumors Accurately identifying patients who will ...
A Singaporean research team has developed CAN-Scan (short for Cancer Scan), a next-generation precision oncology platform ...
Patients with secondary rectal cancer (SRC) after radiotherapy (RT) for prostate cancer have shorter survival compared with matched treatment-naïve patients, (1) but factors explaining this gap have ...
According to a UK study, whole-body MRI showed that patients with arthralgia who had previously received immune checkpoint inhibitor therapy had similar levels of inflammation and erosions as those ...
Researchers at the Center for Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University have preliminarily validated an artificial intelligence (AI) tool to predict ...
Total neoadjuvant treatment (TNT) may offer a promising alternative to surgery for patients with stage I rectal cancer (S1RC), a small study finds. 1 Among patients treated, TNT achieved a 93.7% ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback